Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 20,287 calls trading, 1.0x expected, and implied vol increasing almost 53 points to 131.78%. 7/11 weekly 5.5 calls and 7/11 weekly 5 calls are the most active options, with total volume in those strikes near 6,000 contracts. The Put/Call Ratio is 0.13. Earnings are expected on August 7th.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals
- Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
- Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program
- Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
- Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102